RXRX
RXRX
NASDAQ · Biotechnology

Recursion Pharmaceuticals-A

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.16
-0.02 (-0.63%)
As of Jun 24, 1:26 PM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 8 57%
Hold 6 43%
Sell 0 0%
Price Target
Analyst Price Target +814.6% upside
Low Target $21.05
Average Target $28.90
High Target $39.88
Current Price $3.16
Current
$3.16
Target
$28.90
$21.05 $28.90 avg $39.88
Scenario Analysis
Bear Case
$21.05
566.1%
Low target
Base Case
$28.90
+814.6%
Avg target
Bull Case
$39.88
+1,162.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.18
-56.0% from high
52-Week Low
$2.77
+14.1% from low
50-Day SMA
$4.31
-26.7% vs SMA
200-Day SMA
$4.89
-35.4% vs SMA
RSI (14)
34.7
Neutral
Target vs 52W High
$28.90
+302.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%